MilliporeSigma Articles

  1. Establishing Commercial Manufacturing Services For ADCs 6/3/2024

    Explore how one organization built upon 15+ years of experience and an extensive knowledge base of biologics manufacturing to establish commercial-scale ADC manufacturing capabilities.

  2. Benefit From Leveraging Perfusion Early In Process Development 4/5/2024

    By addressing the complex needs of cell culture from the start, organizations can take steps to optimize their process, ensuring they are maximizing productivity and product quality.

  3. Membrane Filter Pore Size Impact On Colony Size, Microbial Recovery 1/31/2024

    Explore results from a study evaluating the effects of different pore sizes on colony size and microbial recovery using membrane filters.

  4. The Post-Pandemic Supply Chain: Improving Resilience Via Value Chains 11/14/2023

    The COVID-19 pandemic underscored the vulnerability of global supply chains. Explore lessons learned from the pandemic, the concept of supply chain resilience, what to look for in a supplier, and more.

  5. Eliminating USP <88> In Vivo Animal Bioreactivity Testing For Polymer Characterization 8/25/2023

    There has been growing awareness about the environmental and ethical implications of plastics used in bioprocessing. The time for a shift to well-studied, proven in vitro cytotoxicity testing is now.

  6. Market Watch And Perspectives On Vaccines Manufacturing In APAC 8/16/2023

    Nearly forty biopharmaceutical companies, CDMOs, and research institute executives took part in interviews on the future of vaccine manufacturing. Explore the key findings following these interviews.

  7. The State Of Plastics Recycling In BioPharma 8/9/2023

    Recycling plastics from biomanufacturing proves uniquely difficult due to circularity, quality, and infrastructure challenges. Nonetheless, change is underway. Learn how this change is being spearheaded by industry leaders.

  8. Strategies For Ensuring Biomanufacturing Resilience For Biologics 6/29/2023

    Long-term collaboration in resilient biomanufacturing capacity and supply chains ensures the reliable delivery of health technologies. Investigate biomanufacturing resilience strategies for biologics.

  9. Making MS-Based Glycan Analysis Easier 5/2/2022

    Recent technological advances in mass spectrometry based methods have made it easier to overcome the challenges of glycoprotein analysis.

  10. Combining Rapid And EP Bioburden Testing 5/2/2022

    Review a procedure in which compendial testing is complemented by a simultaneous rapid test that uses an identical sample to generate much earlier results while allowing the compendial test to continue.